The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II randomized trial of neoadjuvant (NA) chemotherapy (CT) with or without bevacizumab (Bev) in advanced epithelial ovarian cancer (EOC) (GEICO 1205/NOVA TRIAL).
 
Yolanda García
Speakers' Bureau - Janssen; Roche Pharma AG
 
Ana De Juan
No Relationships to Disclose
 
Cesar Mendiola
Research Funding - Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Pilar Barretina-Ginesta
Employment - Novartis (I)
Speakers' Bureau - Roche Pharma AG
Travel, Accommodations, Expenses - Janssen; Roche Pharma AG
 
Laura Vidal
Employment - Novartis
 
Ana Santaballa
Travel, Accommodations, Expenses - Roche Pharma AG
 
Isabel Bover
No Relationships to Disclose
 
Marta Gil-Martin
No Relationships to Disclose
 
Aránzazu Manzano
No Relationships to Disclose
 
M Jesus Rubio
No Relationships to Disclose
 
Margarita Romeo
No Relationships to Disclose
 
Alfonso Gomez de Liaño
No Relationships to Disclose
 
Elena García-Martínez
No Relationships to Disclose
 
Antonio Gonzalez-Martin
Consulting or Advisory Role - Amgen; MSD; PharmaMar; Roche Pharma AG
Speakers' Bureau - PharmaMar; Roche Pharma AG